Literature DB >> 27707581

Comparative Outcome Analysis of Arthroscopic-Assisted Versus Open Reduction and Fixation of Trans-scaphoid Perilunate Fracture Dislocations.

Won-Taek Oh1, Yun-Rak Choi2, Ho-Jung Kang1, Il-Hyun Koh1, Kyung-Han Lim1.   

Abstract

PURPOSE: To compare union rates and clinical and radiological outcomes of arthroscopic-assisted reduction and fixation with those of open reduction and fixation in patients with trans-scaphoid perilunate fracture dislocations.
METHODS: This retrospective study included consecutive patients with trans-scaphoid PLFDs who underwent arthroscopic-assisted reduction and fixation (group A) or open reduction and fixation (group O), and who were followed up for a minimum of 2 years between May 2005 and March 2013. We excluded initially missed patients. Each different surgeon who was on call had performed each experienced operation. These clinical outcomes were assessed: range of motion, grip strength, Mayo wrist score, and Disabilities of Arm, Shoulder, and Hand (DASH) score. For radiologic outcomes, the scapholunate angle, radiolunate angle, and lunotriquetral distance were measured.
RESULTS: The total number of included patient was 20 (11 in group A and 9 in group O). Scaphoid union occurred in all patients except 1 individual (11 of 11 in group A, and 8 of 9 in group O). At the last follow-up, the mean flexion-extension arc was significantly greater in group A (125.0°) than in group O (105.6°) (P = .028). The mean grip strength was 81.1% that of the contralateral side in group A and 80.9% in group O (P = .594). The mean Mayo wrist score was 85.5 in group A and 79.4 in group O (P = .026), and the mean DASH score was 10.6 in group A and 20.8 in group O (P = .001); however, only the DASH score showed a minimum clinically important difference. The mean scapholunate angle, radiolunate angle, and lunotriquetral distance were similar between the 2 groups: 47.2°, 1.7°, and 2.0 mm in group A and 48.8°, 5.6°, and 2.1 mm in group O, respectively.
CONCLUSIONS: Although both arthroscopic and open techniques achieved stability of the injured wrists in patients with trans-scaphoid PLFDs, it is shown that the arthroscopic-assisted technique showed a clinically meaningful better DASH score and greater flexion-extension arc with other parameters being similar. LEVEL OF EVIDENCE: Level III, retrospective comparative study.
Copyright © 2016 Arthroscopy Association of North America. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27707581     DOI: 10.1016/j.arthro.2016.07.018

Source DB:  PubMed          Journal:  Arthroscopy        ISSN: 0749-8063            Impact factor:   4.772


  5 in total

1.  Mid-term clinical and radiographic outcomes of perilunate injuries treated with open reduction and internal fixation.

Authors:  İlker Çolak; Güven Bulut; Halil İbrahim Bekler; Gültekin Sıtkı Çeçen; Deniz Gülabi
Journal:  Acta Orthop Traumatol Turc       Date:  2021-01       Impact factor: 1.511

2.  Perilunate Injury Timing and Treatment Options: A Systematic Review.

Authors:  Mark J W van der Oest; Liron S Duraku; Madina Artan; Caroline A Hundepool; Dominic M Power; Vaikunthan Rajaratnam; J Michiel Zuidam
Journal:  J Wrist Surg       Date:  2021-10-05

3.  Chronic Isolated Dorsal Dislocation of the Lunate. A Rare Presentation of Carpal Instability.

Authors:  Diego Alonso-Tejero; Gonzalo Luengo-Alonso; Verónica Jiménez-Díaz; Lorena García-Lamas; Miguel Ángel Porras-Moreno; David Cecilia-López
Journal:  Strategies Trauma Limb Reconstr       Date:  2022 Jan-Apr

Review 4.  [Advances in diagnosis and treatment of acute scaphoid fractures].

Authors:  Chenguang Yang; Liang Chen; Shaonan Hu
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2019-04-15

5.  Long-term results of trans-scaphoid perilunate fracture dislocations treated by open reduction and internal fixation.

Authors:  Xiao-Jun Yu; Shan-Xi Wang; Xin-Zhen Guo; Qi-Kun Liu; Ying-Guang Wang; Yun-Kun Qu; Hao Kang; Yuan Bao
Journal:  BMC Musculoskelet Disord       Date:  2022-08-31       Impact factor: 2.562

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.